These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7814811)

  • 1. Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination.
    Fujiyama S; Odoh K; Kuramoto I; Mizuno K; Tsurusaki R; Sato T
    J Hepatol; 1994 Oct; 21(4):641-5. PubMed ID: 7814811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination].
    Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R
    Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    J Infect Dis; 1993 Sep; 168(3):740-3. PubMed ID: 8394864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous passive and active immunization against hepatitis A.
    Leentvaar-Kuijpers A; Coutinho RA; Brulein V; Safary A
    Vaccine; 1992; 10 Suppl 1():S138-41. PubMed ID: 1335646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against hepatitis A].
    Giusti G; Russo M
    Recenti Prog Med; 1992 Jun; 83(6):313-20. PubMed ID: 1323136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis A vaccination: schedule for accelerated immunization.
    Müller R; Chriske H; Deinhardt F; Jilg J; Theilmann L; Hess G; Hofmann F; Hopf U; Stickl H; Maiwald H
    Vaccine; 1992; 10 Suppl 1():S124-5. PubMed ID: 1335641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence of anti-hepatitis A antibodies in Czech soldiers serving in U.N. forces--suggestions for a hepatitis A vaccination schedule].
    Beran J; Douda P; Prymula R; Splino M; Gál P; Rychlý R
    Epidemiol Mikrobiol Imunol; 1995 Dec; 44(4):165-8. PubMed ID: 8556244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers.
    Wagner G; Lavanchy D; Darioli R; Pécoud A; Brulein V; Safary A; Frei PC
    Vaccine; 1993; 11(10):1027-32. PubMed ID: 8212822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
    Shouval D; Ashur Y; Adler R; Lewis JA; Armstrong ME; Davide JP; McGuire B; Kuter B; Brown L; Miller W
    Vaccine; 1993; 11 Suppl 1():S9-14. PubMed ID: 8383390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection.
    Robertson BH; D'Hondt EH; Spelbring J; Tian H; Krawczynski K; Margolis HS
    J Med Virol; 1994 Jul; 43(3):249-51. PubMed ID: 7931186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjects.
    Bienzle U; Bock HL; Meister W; Clemens R; Kruppenbacher JP
    Lancet; 1993 Apr; 341(8851):1028. PubMed ID: 8096914
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis A antibody in blood donors in North East Thames region: implications to prevention policies.
    Scott NJ; Harrison JF; Zuckerman AJ
    Epidemiol Infect; 1989 Oct; 103(2):377-82. PubMed ID: 2553466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis A antibody prevalence among young adults in Israel--the decline continues.
    Gdalevich M; Grotto I; Mandel Y; Mimouni D; Shemer J; Ashkenazi I
    Epidemiol Infect; 1998 Oct; 121(2):477-9. PubMed ID: 9825802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of anti-hepatitis A in patients with chronic liver disease].
    Diago M; Luján M; García V; Cors R; Carbonell P; Tuset C; Gimeno J
    Gastroenterol Hepatol; 1998; 21(7):324-6. PubMed ID: 9808894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy.
    Moschen ME; Floreani A; Zamparo E; Baldo V; Majori S; Gasparini V; Trivello R
    Eur J Epidemiol; 1997 Dec; 13(8):875-8. PubMed ID: 9476815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A vaccine.
    Bader TF
    Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus.
    Stewart DR; Morris TS; Purcell RH; Emerson SU
    J Infect Dis; 1997 Sep; 176(3):593-601. PubMed ID: 9291304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of vaccine-induced antibody to hepatitis A virus.
    Wiedermann G; Ambrosch F; André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S129-31. PubMed ID: 1335643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.